Methods are provided for preventing, inhibiting, or treating intimal hyperplasia in a patient who has undergone a coronary bypass procedure that include providing a solution comprising DCA added to water and administering the solution orally to a patient to prevent, inhibit, or treat intimal hyperplasia.